Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: a multicentre, double-blind, placebo … MMJ van Eijk, KCB Roes, MLH Honing, MA Kuiper, A Karakus, ... The Lancet 376 (9755), 1829-1837, 2010 | 444 | 2010 |
Dealing with missing outcome data in randomized trials and observational studies RHH Groenwold, ART Donders, KCB Roes, FE Harrell Jr, KGM Moons American journal of epidemiology 175 (3), 210-217, 2012 | 416 | 2012 |
Reporting of covariate selection and balance assessment in propensity score analysis is suboptimal: a systematic review MS Ali, RHH Groenwold, SV Belitser, WR Pestman, AW Hoes, KCB Roes, ... Journal of clinical epidemiology 68 (2), 122-131, 2015 | 222 | 2015 |
Shewhart-type control charts for individual observations KCB Roes, RJMM Does, Y Schurink Journal of Quality Technology 25 (3), 188-198, 1993 | 125 | 1993 |
Long-term follow-up assessing renal angiomyolipoma treatment patterns, morbidity, and mortality: an observational study in tuberous sclerosis complex patients in the Netherlands MJC Eijkemans, W van der Wal, LJ Reijnders, KCB Roes, ... American Journal of Kidney Diseases 66 (4), 638-645, 2015 | 122 | 2015 |
Aiming for a representative sample: Simulating random versus purposive strategies for hospital selection LR Van Hoeven, MP Janssen, KCB Roes, H Koffijberg BMC medical research methodology 15, 1-9, 2015 | 120 | 2015 |
Room for improvement in conducting and reporting non-inferiority randomized controlled trials on drugs: a systematic review G Wangge, OH Klungel, KCB Roes, A de Boer, AW Hoes, MJ Knol PLoS One 5 (10), e13550, 2010 | 115 | 2010 |
Multimodal nocturnal seizure detection in a residential care setting: a long-term prospective trial J Arends, RD Thijs, T Gutter, C Ungureanu, P Cluitmans, J Van Dijk, ... Neurology 91 (21), e2010-e2019, 2018 | 107 | 2018 |
Recommendations for the design of small population clinical trials S Day, AH Jonker, LPL Lau, RD Hilgers, I Irony, K Larsson, KCB Roes, ... Orphanet journal of rare diseases 13, 1-9, 2018 | 98 | 2018 |
Subgroup analyses in confirmatory clinical trials: time to be specific about their purposes J Tanniou, I Van Der Tweel, S Teerenstra, KCB Roes BMC medical research methodology 16, 1-15, 2016 | 93 | 2016 |
Methods to control for unmeasured confounding in pharmacoepidemiology: an overview MJ Uddin, RHH Groenwold, MS Ali, A de Boer, KCB Roes, ... International journal of clinical pharmacy 38, 714-723, 2016 | 92 | 2016 |
Estimation of between-trial variance in sequential meta-analyses: a simulation study PW Novianti, KCB Roes, I van der Tweel Contemporary clinical trials 37 (1), 129-138, 2014 | 84 | 2014 |
Propensity score balance measures in pharmacoepidemiology: a simulation study MS Ali, RHH Groenwold, WR Pestman, SV Belitser, KCB Roes, AW Hoes, ... Pharmacoepidemiology and drug safety 23 (8), 802-811, 2014 | 80 | 2014 |
Multimodal seizure detection: A review FSS Leijten, Dutch TeleEpilepsy Consortium, J van Andel, C Ungureanu, ... Epilepsia 59, 42-47, 2018 | 79 | 2018 |
Current statistical considerations and regulatory perspectives on the planning of confirmatory basket, umbrella, and platform trials O Collignon, C Gartner, AB Haidich, R James Hemmings, B Hofner, ... Clinical Pharmacology & Therapeutics 107 (5), 1059-1067, 2020 | 75 | 2020 |
Mirtazapine effects on alertness and sleep in patients as recorded by interactive telecommunication during treatment with different dosing regimens FS Radhakishun, J van den Bos, BCJM van der Heijden, KCB Roes, ... Journal of clinical psychopharmacology 20 (5), 531-537, 2000 | 75 | 2000 |
Shewhart-type charts in nonstandard situations KCB Roes, RJMM Does Technometrics 37 (1), 15-24, 1995 | 71 | 1995 |
Rare disease registries: potential applications towards impact on development of new drug treatments MC Jansen-Van Der Weide, CMW Gaasterland, KCB Roes, C Pontes, ... Orphanet Journal of Rare Diseases 13, 1-11, 2018 | 68 | 2018 |
Multimodal, automated detection of nocturnal motor seizures at home: Is a reliable seizure detector feasible? J van Andel, C Ungureanu, J Arends, F Tan, J Van Dijk, G Petkov, ... Epilepsia Open 2 (4), 424-431, 2017 | 59 | 2017 |
Safety of Switching From a Vitamin K Antagonist to a Non–Vitamin K Antagonist Oral Anticoagulant in Frail Older Patients With Atrial Fibrillation: Results of the FRAIL-AF … LPT Joosten, S van Doorn, PM van de Ven, BTG Köhlen, MC Nierman, ... Circulation 149 (4), 279-289, 2024 | 57 | 2024 |